[Form 4] Hims & Hers Health, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Insider sale by HIMS officer: The Form 4 shows Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc. (HIMS), sold 2,571 shares of Class A common stock on 08/25/2025 at a price of $44.53 per share. After the reported sale, Boughton beneficially owned 150,450 shares. The filing was signed by an attorney-in-fact on 08/26/2025 and indicates the sale was executed under the reporting person’s authority.

Positive

• Reporting complied with Section 16: Form 4 filed and signed, disclosing the transaction.
• Substantial retained ownership: Boughton continues to beneficially own 150,450 Class A shares after the sale.

Negative

• Insider sale occurred: 2,571 Class A shares were sold on 08/25/2025 at $44.53 per share.

Insights

Securities Analyst

TL;DR: An officer executed a small open-market sale, reducing holdings but retaining a substantial position.

The transaction is a straightforward disposition of 2,571 Class A shares at $44.53 each, leaving the reporting officer with 150,450 shares. The sale size represents a small fraction of the remaining holdings and does not include derivative activity. From a disclosure standpoint, the Form 4 is complete and shows the officer remains a significant holder.

Corporate Governance Expert

TL;DR: Routine insider sale disclosed properly; continued significant ownership is maintained.

The filing meets Section 16 disclosure requirements and was signed by an attorney-in-fact. There are no amendments or derivative transactions disclosed. The officer’s remaining beneficial ownership of 150,450 shares is explicitly reported, which is relevant for evaluating insider alignment with shareholders.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Boughton Soleil

(Last) (First) (Middle)

2269 CHESTNUT STREET, #523

(Street)

SAN FRANCISCO CA 94123

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Legal Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/25/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	08/25/2025		S		2,571	D	$44.53	150,450	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Kimberly Mather, Attorney-in-Fact for Soleil Boughton	08/26/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did HIMS officer Soleil Boughton report?

Boughton sold 2,571 Class A shares on 08/25/2025 at a price of $44.53 per share, as reported on Form 4.

How many HIMS shares does Soleil Boughton own after the reported sale?

150,450 Class A shares of Hims & Hers are beneficially owned by Boughton following the transaction.

Was the Form 4 for HIMS properly signed and dated?

Yes. The form was signed by Kimberly Mather as Attorney-in-Fact for Soleil Boughton on 08/26/2025.

Did the filing report any derivative transactions for HIMS insiders?

No. Table II for derivative securities contains no reported transactions or holdings.

Was the transaction coded or noted as part of a trading plan (10b5-1)?

The form indicated a 10b5-1 box was checked. (The top section shows the box for a plan-related transaction was marked.)